2 drug(s) with this reaction
1,412 total reports
Herpes Simplex has been reported as an adverse reaction across 2 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 1,412 adverse event reports mention herpes simplex in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with herpes simplex, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have herpes simplex listed in their FDA adverse event reports, sorted by report count:
In addition to herpes simplex, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
2 drug(s) manufactured by Haleon Us Holdings Llc have herpes simplex listed in their FDA adverse event reports: GLYCERIN, LIDOCAINE, DOCOSANOL.
There are a combined 1,412 reports of herpes simplex across 2 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.